Inve US ▾
PMPM

Philip Morris International (PM) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Consumer Staples· Apr 22, 2026

Source: earnings call transcript

Executive summary

Philip Morris International Inc. Q1 FY26 — Strong Smoke-Free Growth and Reaffirmed Outlook

Philip Morris International delivered a strong Q1 FY26, driven by outstanding performance in its international smoke-free business, particularly IQOS and VEEV, and robust pricing power. This momentum, coupled with efficient cost management, offset anticipated headwinds in U.S. ZYN shipments and structural declines in combustible volumes. The company reconfirmed its full-year currency-neutral growth outlook, underscoring confidence in its smoke-free transformation and ability to navigate macroeconomic uncertainties.

Highlights

5
  • Adjusted diluted earnings per share grew by an impressive +16% to $1.96, exceeding expectations.

  • International smoke-free business delivered double-digit volume growth, mid-teens organic top-line progression, and high-teens organic gross profit growth (almost +30% in dollar terms).

  • Net revenues reached over $10 billion, representing a +9% increase in reported terms and +2.7% organically, surpassing expectations.

  • Adjusted gross profit grew by +10% to $6.9 billion, reflecting +3.8% organic growth and +70 basis points of organic gross margin expansion.

  • IQOS delivered +10.9% adjusted in-market sales growth, with Taiwan becoming the most successful major IQOS launch market to date with almost 6% national exit offtake share in March.

Concerns

5
  • Total cigarette volumes declined by -1.9%, with international combustible volumes down -5.1%, at the more negative end of expectations.

  • U.S. ZYN segment financial performance was challenging due to increased investment, strong Q1 2025 comparison, and channel inventory overhang normalization impacting shipments.

  • Oral smoke-free volume declined by -16%, notably reflecting U.S. shipment and inventory headwinds and timing dynamics in the Nordics.

  • The Middle East conflict had a small impact on global travel retail and certain markets, affecting both combustible and HTU shipments.

  • A challenging economic environment contributed to higher levels of illicit consumption in certain markets and excise increases drove significant industry declines in some countries.

Guidance & targets

CategoryTargetConfidence
Full-year 2026 shipment volumes
broadly stable
high materiality
High
Full-year 2026 organic net revenue growth
+5% to +7%
high materiality
High
Full-year 2026 organic operating income growth
+7% to +9%
high materiality
High
Full-year 2026 currency-neutral adjusted diluted EPS growth
+7.5% to +9.5%
high materiality
High
Full-year 2026 currency tailwind (EPS)
$0.25
medium materiality
High
Full-year 2026 adjusted diluted EPS forecast
$8.36 to $8.51
high materiality
High
Full-year 2026 adjusted diluted EPS growth (dollar terms)
+10.9% to +12.9%
high materiality
High
Q2 2026 HTU shipment volume
40 billion to 42 billion
medium materiality
High
Q2 2026 HTU adjusted IMS growth
slower
medium materiality
Medium
Q2 2026 cigarette shipment volume decline
low single-digit
medium materiality
High
Q2 2026 organic net revenue growth
mid-single-digit
medium materiality
High
Q2 2026 operating income progression
solid
medium materiality
Medium
Q2 2026 adjusted diluted EPS
$2.02 to $2.07
high materiality
High
Full-year 2026 cigarette volume decline
around 3%
medium materiality
High
Full-year 2026 combustible pricing variance
more than 6%
medium materiality
High
SG&A progression for 2026
organically at or below the level of net revenue growth
medium materiality
High
Full-year 2026 organic margin expansion
on track
medium materiality
High
Full-year 2026 global smoke-free growth
strong, supported by high single-digit volume progression
high materiality
High
ZYN shipments (Q2 2026)
broadly track offtake growth, approx. 180 million cans
medium materiality
High
ZYN shipments (Q3 2026)
approx. 205 million cans
medium materiality
High
ZYN shipments (Q4 2026)
approx. 200 million cans
medium materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
International Smoke-Free Business
Delivered outstanding performance, driving gross margin expansion. Primarily driven by IQOS, with increasing contribution from ZYN and VEEV.
Volume growth: +11.9%Gross margin expansion: +210 bps to 70%
—+15.8% organic—+19.4% organic gross profit growth
International Combustible Business
Robust financial performance, with strong pricing and effective cost management outweighing volume mix headwinds.
Volume decline: -5.1%Gross margin expansion: +190 bps organically
—+1% organic net revenue growth—+3.9% organic gross profit growth
Global Smoke-Free Business (PMI as a whole)
Delivered solid organic growth despite dynamics in the U.S. Expected to see strong global growth for the full year.
—+5.3% organic net revenue growth—+3.9% organic gross profit growth
Europe (IQOS)
Very good performance across the region, despite disruption in Ukraine and initial impact from EU flavor ban in Poland. Double-digit growth continued in Italy.
Adjusted IMS volumes (excluding flavor ban markets): around +8% growth
—+5.4% adjusted IMS volume——
Japan (IQOS)
Robust growth demonstrating ongoing momentum, despite high competitive intensity. Q1 included a 0.5 billion unit consumer pantry loading benefit ahead of April 1 excise price increase.
Adjusted IMS volumes (excluding consumer pantry loading): around +6% growthAdjusted market share: 34.9% (record)Capture of industry heat-not-burn volumes: close to 70%
—+10.4% adjusted IMS volumes——
U.S. (ZYN)
ZYN continues to lead the nicotine pouch category. Shipment decline reflects inventory normalization from Q1 2025 rebuild and end-2025 surplus.
Q1 shipment: 155 million cans
—+10% offtake growth——

PM operating KPIs by quarter

PM operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Sep 2025 Q3 FY25This call Mar 2026 Q1 FY26Change vs prior quarter
Shipment volume US ZYN
165M Switching categories now to ZYN, where we continued -- where continued strong demand supported Q4 US shipment volume growth of plus 42% year-on-year to 165 million cans. Source: earnings call transcript
202M ZYN, once again, delivered strong growth in the US with shipments increasing by an impressive plus 53% to reach 202 million cans, exceeding our initial expectations as demand remained strong and production capacity increased ahead of schedule in the latter part of March, enabling some initial replenishment of trade inventories. Source: earnings call transcript
205M Driven by the strong performance in the fast-growing nicotine pouch category, US shipments grew by plus 37% to 205 million cans, ahead of expectation. Source: earnings call transcript
155M While offtake volume increased, Q1 shipment declined to 155 million can, reflecting the inventory dynamic explained last quarter, which I will now briefly recap. Source: earnings call transcript
-24.4%
Markets Nicotine pouches
37 We launched nicotine pouches in 6 new markets during the quarter to reach a total of 37 worldwide, including Italy, Romania and Thailand. Source: earnings call transcript
38 We are now in 38 markets globally, following Q1 launches in the UAE and Colombia and you see at least all addressable market has meaningful opportunity given the unit [indiscernible]. Source: earnings call transcript
47 Can shipment grew by plus 36% on a global basis with a presence now in 47 markets. Source: earnings call transcript
—+23.7%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
ZYN Innovationsroadmap
IQOS bonds by IQOSexpansion

Risks & headwinds

Global economic outlook uncertainty ongoing

unquantified

Mitigation:Strong financial performance and structural growth fundamentals provide confidence in navigating external headwinds.

Middle East conflict Q1 FY26, ongoing

small impact on global travel retail and certain markets for both combustible and HTUs; increased energy prices and some disruption in energy supply

Mitigation:Factored in some increases in transport, energy, and other input costs; closely monitoring developments to assess mid- to long-term impact.

Challenging economic environment Q1 FY26

contributed to higher level of illicit consumption in certain markets

Mitigation:Strong pricing power and efficient cost management help to offset volume mix headwinds.

Excise increases in countries (e.g., Mexico) Q1 FY26

drove a significant industry decline

Mitigation:Strong pricing power of the portfolio helps mitigate impact.

Dynamic competitive landscape (U.S. ZYN) ongoing

portfolio does not yet address all of the most dynamic strength and flavor segments

Mitigation:Sharply focused on innovating and preparing for new product launches in the coming months to address these segments.

Complex and dynamic regulatory environment (U.S.) ongoing

impacts timely innovation and the switching of legal smoker to better alternative

Mitigation:Engaging with the FDA, robust science supporting applications, and following regulatory processes diligently.

Japan excise tax increase (April 1) Q2 FY26

expected to reflect the reversal of consumer pantry loading and the price increases

Mitigation:Confident in the long-term growth of IQOS and the wider category in Japan.

Q&A highlights

How much of a priority is optimizing international smoke-free margins given high levels and growth potential? Also, what is the strategy for US ZYN pricing given widened price gaps?

Management stated that maximizing volume is the primary objective for international smoke-free, as the dollar profit per unit is already significantly higher than combustibles. For US ZYN, the intention is to maintain its premium positioning as the market leader, continuously monitoring pricing parameters to optimize this objective.

“So maximizing volume, of course, is a big objective. But as we are building the portfolio, we are building a very attractive brand with IQOS very differentiated, but look at what we're doing with VEEV. So they are coming more like these brands, if you want, Viva in international. They are much smaller than IQOS at this stage, but we are also working on the profitability of these 2 brands.”

asked by Eric Serotta · answered by Jacek Olczak

3 min read 6 chapters

Detailed narrative

International Smoke-Free Momentum

The international smoke-free business delivered an outstanding quarter, with organic net revenue growth of +15.8% and organic gross profit growth of +19.4%. This was primarily driven by IQOS, which saw +10.9% adjusted in-market sales growth across various markets, including strong performance in Europe and Japan.

New market launches for smoke-free products, including ZYN in Portugal and Kenya and VEEV in Egypt, expanded the footprint to 108 markets, with 55 now multi-category. VEEV reinforced its position as the fastest-growing international closed pod brand, becoming joint #1 in Europe in Q4 '25 and almost doubling IMS volumes.

U.S. ZYN Dynamics and Innovation

U.S. ZYN continued to lead the nicotine pouch category with +10% offtake growth in Q1, as estimated by Nielsen. However, Q1 shipments declined to 155 million cans due to the normalization of approximately 25 million cans of surplus inventory from the end of 2025.

The company expects ZYN shipments to broadly track offtake growth in future quarters, with underlying volumes estimated at 180 million cans for Q2. Management is focused on launching new ZYN innovations in the coming months to address dynamic strength and flavor segments and drive renewed momentum, while navigating the complex regulatory environment.

Combustibles Resilience and Pricing Power

Despite a -1.9% decline in total shipments and -5.1% in international combustible volumes, the combustible business demonstrated resilience. Strong pricing, adding +5 points to overall net revenue growth and +8.5% for combustibles, was a key driver, with notable contributions from Turkey, Indonesia, and Mexico.

This, combined with efficient cost management, allowed international combustible gross profit to grow +3.9% organically and gross margins to expand +190 basis points, offsetting volume and mix headwinds.

Margin Expansion and Cost Efficiency

Adjusted operating income margins expanded by +40 basis points to over 41%, supported by a positive currency impact. Organic gross margin expansion of +70 basis points was driven by strong pricing, operating leverage, and the continued benefit of smoke-free mix.

The company realized approximately $150 million in gross cost efficiencies in Q1 and remains on track for full-year organic margin expansion, despite increased reinvestment in the smoke-free portfolio and commercial programs.

Regulatory Landscape and Product Pipeline

Philip Morris International continues to engage with the FDA on regulatory matters. The previous version of IQOS has been reauthorized as a modified risk tobacco product, and the company is pursuing authorization for IQOS ILUMA. The PMTA application for ZYN Ultra remains under active scientific review, with management optimistic about its launch in the coming months.

The company advocates for differentiated, low excise duties on reduced-risk products, aligning with the FDA's public health goals to encourage switching from combustibles.

Strategic Outlook and Sustainability Initiatives

The company reconfirmed its full-year 2026 currency-neutral guidance, including organic net revenue growth of +5% to +7% and organic operating income growth of +7% to +9%. An updated currency tailwind of $0.25 leads to an adjusted diluted EPS forecast of $8.36 to $8.51.

PMI also published its Value Report 2025, highlighting progress on sustainability priorities and introducing the Value Plan 2030, a framework focused on consumers, circularity, workforce, climate, and nature, integrated with its business strategy.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.